Literature DB >> 15149601

During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria.

Peter K Kim1, Matthew G Annis, Paulina J Dlugosz, Brian Leber, David W Andrews.   

Abstract

In healthy cells the antiapoptotic protein Bcl-2 adopts a topology typical of tail-anchored proteins with only the hydrophobic carboxyl terminus inserted into the membrane, as shown by labeling cell lysates with a membrane-impermeant sulfhydryl-specific reagent. Induction of apoptosis in cells triggered a change in the conformation of Bcl-2 such that cysteine 158 near the base of helix 5 inserted into the lipid bilayer of both endoplasmic reticulum and mitochondria where it was protected from labeling. Addition of a peptide corresponding to the BH3 domain of the proapoptotic protein Bim to cell lysates triggered a similar conformational change in Bcl-2, demonstrating that preexisting, membrane-bound Bcl-2 proteins change topology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149601     DOI: 10.1016/s1097-2765(04)00263-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

1.  Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

Authors:  Zhi Zhang; Suzanne M Lapolla; Matthew G Annis; Mary Truscott; G Jane Roberts; Yiwei Miao; Yuanlong Shao; Chibing Tan; Jun Peng; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

2.  Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif.

Authors:  Jingzhen Ding; Zhi Zhang; G Jane Roberts; Mina Falcone; Yiwei Miao; Yuanlong Shao; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

3.  Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule.

Authors:  Lixia Zhao; Feng He; Haiyang Liu; Yushan Zhu; Weili Tian; Ping Gao; Hongping He; Wen Yue; Xiaobo Lei; Biyun Ni; Xiaohui Wang; Haijing Jin; Xiaojiang Hao; Jialing Lin; Quan Chen
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Transmembrane protein topology mapping by the substituted cysteine accessibility method (SCAM(TM)): application to lipid-specific membrane protein topogenesis.

Authors:  Mikhail Bogdanov; Wei Zhang; Jun Xie; William Dowhan
Journal:  Methods       Date:  2005-06       Impact factor: 3.608

5.  Bcl-2 changes conformation to inhibit Bax oligomerization.

Authors:  Paulina J Dlugosz; Lieven P Billen; Matthew G Annis; Weijia Zhu; Zhi Zhang; Jialing Lin; Brian Leber; David W Andrews
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

6.  Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2.

Authors:  Chibing Tan; Paulina J Dlugosz; Jun Peng; Zhi Zhang; Suzanne M Lapolla; Scott M Plafker; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2006-03-29       Impact factor: 5.157

7.  NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL.

Authors:  Thomas J Malia; Gerhard Wagner
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

8.  The C-terminus of cytochrome b5 confers endoplasmic reticulum specificity by preventing spontaneous insertion into membranes.

Authors:  Matthew P A Henderson; Yeen Ting Hwang; John M Dyer; Robert T Mullen; David W Andrews
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

9.  tBid elicits a conformational alteration in membrane-bound Bcl-2 such that it inhibits Bax pore formation.

Authors:  Jun Peng; Chibing Tan; G Jane Roberts; Olga Nikolaeva; Zhi Zhang; Suzanne M Lapolla; Steve Primorac; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2006-09-27       Impact factor: 5.157

Review 10.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.